Kimia Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 309.27 million compared to INR 375.03 million a year ago. Revenue was INR 312.49 million compared to INR 385.63 million a year ago. Net loss was INR 12.68 million compared to net income of INR 36.09 million a year ago. Basic loss per share from continuing operations was INR 0.27 compared to basic earnings per share from continuing operations of INR 0.75 a year ago. Diluted loss per share from continuing operations was INR 0.27 compared to diluted earnings per share from continuing operations of INR 0.75 a year ago.
For the six months, sales was INR 617.96 million compared to INR 623.53 million a year ago. Revenue was INR 622.92 million compared to INR 637.84 million a year ago. Net loss was INR 9.5 million compared to net income of INR 55.84 million a year ago. Basic loss per share from continuing operations was INR 0.2 compared to basic earnings per share from continuing operations of INR 1.18 a year ago. Diluted loss per share from continuing operations was INR 0.2 compared to diluted earnings per share from continuing operations of INR 1.18 a year ago.